ZEISS Acquires D.O.R.C., Eyeing Future Innovations in Ophthalmology

05 April 2024 | Friday | News

Carl Zeiss Meditec AG has officially completed the acquisition of Dutch Ophthalmic Research Center (D.O.R.C.) from Eurazeo SE, marking a pivotal shift in the industry's landscape.
Image Source : Public Domain

Image Source : Public Domain

 This acquisition, now fully approved by regulatory bodies, not only expands ZEISS's ophthalmic portfolio but also reinforces its standing as a trailblazer in digitally connected workflow solutions aimed at tackling various eye conditions, including retina and cornea disorders, cataract, glaucoma, and refractive errors.

Dr. Markus Weber, President and CEO of Carl Zeiss Meditec AG, underscored the merger's significance, expressing enthusiasm for the integration of D.O.R.C.’s team into the ZEISS family. This union heralds a new era of innovation and solution-driven approaches for customers worldwide. The integration is envisioned to harness the collective expertise of both entities to pioneer breakthrough innovations.

Euan S. Thomson, Ph.D., President of Ophthalmology at ZEISS, highlighted the merger's capacity to offer unparalleled technological portfolios and digital workflows. The ambition is clear: to ascend to the top echelon of global ophthalmology by enhancing workflow solutions, broadening portfolio offerings, and expanding market presence, especially in the posterior surgery segment.

Pierre Billardon, CEO of D.O.R.C., reflected on the merger as a milestone in their history of surgeon-inspired innovation, anticipating an accelerated pace of advancements in ophthalmic surgery. This collaboration aims to extend their reach and impact, fueling advancements that promise to revolutionize patient care.

ZEISS's acquisition of D.O.R.C. is a strategic move designed to deliver an unmatched end-to-end solution in the digitally-connected ZEISS Retina Surgery Workflow. The integration of D.O.R.C.’s EVA NEXUS® platform with ZEISS's extensive lineup of diagnostic and therapeutic devices is poised to transform clinical workflows in ophthalmology, offering surgeons and their patients more efficient and effective treatment options.

The EVA NEXUS platform, renowned for its advanced dual-function system, enriches ZEISS's offerings, providing a comprehensive range of accessories, instruments, and liquids for vitreo-retinal (VR) and combined cataract procedures. This synergy between D.O.R.C.’s and ZEISS's portfolios ensures a broader selection of surgical solutions, tailored to meet the diverse needs and preferences of surgeons.

With this acquisition, healthcare professionals can anticipate a broader spectrum of digitally connected devices and workflow solutions, supporting efficient clinical workflows from pre-operative stages to the surgical operating room. This collaboration between ZEISS and D.O.R.C. sets the stage for significant advancements in ophthalmology, enhancing patient outcomes and setting new standards for innovation and care in the field.


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in